Michael Sassano

Michael Sassano

Benzinga Contributor

About
Michael Sassano was an early investor in the United States cannabis industry and now heads SOMAÍ Pharmaceuticals, a next-generation biotech company centred on the cultivation, manufacturing, and distribution of GMP-certified cannabinoid-containing ph...
The Medical Cannabis Explosion Just Got Real
The global cannabis trifecta has hit! The United States has finally rescheduled cannabis, moving it to Schedule III; the Department of Health and Human Services (HHS) and Food and Drug Administration (FDA) have released a report deeming cannabis a safe medicine; and Germany has removed the narcotics derivation from cannabis, making it easy to prescribe. 
Japanese Cannabis Reform Is Almost Here
In November 2023, the Japanese Ministry of Health, Labor and Welfare (MHLW) was tasked with developing rules and standards for THC levels in Japanese cannabis products.
The Surging Tides Of Global Medical Cannabis Markets
You may not see it or even hear about it but have no doubts: an enormous regulatory framework tsunami pushing global medical cannabis is happening right now. 
2024 New Global Emerging Cannabis Markets Predictions
As the entire cannabis world is abuzz and cannabis stocks are shooting through the roof with the potential United States rescheduling of cannabis to Schedule III and
How Australian Cannabis Brands Can Enter Europe
Cannabis has long been trending as a global product, providing regional players opportunities to reach outside their home countries and expand to international markets. Australia has fantastic cannabis growers, producers, brands, and clinics, and those companies looking to stretch across the seas can follow a few easy steps to ensure success.